Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
36 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsNovo Nordisk A/S: CHMP endorses EU label update of SaxendaŽ based on the LEADER trial
(WorldNews Denmark)

 
 

22 june 2017 21:50:03

 
Novo Nordisk A/S: CHMP endorses EU label update of SaxendaŽ based on the LEADER trial
(WorldNews Denmark)
 


CHMP endorses EU label update of SaxendaŽbased on the LEADER trial Bagsvćrd, Denmark, 22 June 2017 - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), has endorsed an update of the EU label for SaxendaŽ. This update is based on the results from the LEADER trial which investigated the long-term effects of VictozaŽin people with type 2 diabetes and established cardiovascular disease. The CHMP has previously concluded that, although the SaxendaŽdosing of liraglutide 3.0 mg was not investigated in the LEADER trial, the results would also be supportive for the assessment of SaxendaŽfor any potential...


 
12 viewsCategory: General > Europe > Denmark
 
Collections for the disaster victims in the Uummannaq area
(WorldNews Denmark)
Novo Nordisk A/S: CHMP endorses EU label update of Saxenda
(WorldNews Denmark)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten